The drug makes tumours visible to the immune system and enables patients to respond to immunotherapy treatments

Experimental tablet produces encouraging results in patients with world’s most common forms of disease

An experimental pill can shrink tumours by nearly a third in six of the world's most difficult to treat cancers, early trial results have found.

The drug makes tumours visible to the immune system and enables patients to respond to immunotherapy treatments